ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · Q4 FY26

Johnson Pharmacare Q4 FY26 Results: Net Loss of ₹55.6 Cr, Loss Widens

Johnson Pharmacare Ltd reported a net loss of ₹55.6 Cr for Q4 FY26.

Q4 FY26 at a glance · ₹ crore
MetricQ4 FY26Q3 FY26Q4 FY25
Revenue from operations0.00.00.0
Other income1.60.0-0.3
Total income1.60.0-0.3
Profit before exceptional items & tax-41.3-0.1-0.3
Exceptional items14.30.00.2
Profit before tax-55.6-0.1-0.5
Net profit-55.6-0.1-0.5
Operating marginn/m0.0%166.7%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Source

BSE results filing, NSE: SUNSHINE. Figures extracted from the filing.

Read the filing ↗

Johnson Pharmacare Ltd: key numbers

Share price
₹0.47
Market cap
₹25.85 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹-55.73 Cr
P/E (TTM)
-0.5×Sector 46.8×
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Johnson Pharmacare Ltd

All →